Urolithiasis pp 417-420 | Cite as

Theme Poster Session: Oxalate

  • L. H. Smith
  • B. Baggio

Abstract

Oxalate with calcium forms the most-common crystal salt in the majority of calculi formed within the urinary tract. These ions are present in an equal molar ratio in the crystals of calcium oxalate monohydrate and calcium oxalate dihydrate. The greatest crystalline mass from a solution supersaturated with calcium oxalate is made when these ions are present at equal molar concentrations. In normal urine, the ratio between the molar concentration of calcium and oxalate is usually greater than 3:1 and often 5:1 or greater. Thus, increases in the calcium concentration would be expected to have a lesser effect on supersaturation and crystalline mass than increases in the oxalate concentration, making oxalate concentration a major determinant in the formation of calcium oxalate stones within the urinary tract (1–3).

Keywords

Calcium Oxalate Urinary Oxalate Oxalate Concentration Oxalate Excretion Primary Hyperoxaluria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    WG Robertson and M Peacock, Nephron 26: 105 (1980).PubMedCrossRefGoogle Scholar
  2. 2.
    L Larsson and H-G Tiselius, Mineral Electrolyte Metab. 13: 242 (1987).Google Scholar
  3. 3.
    LH Smith, in: this volume, p. 303, 405, 453, 821Google Scholar
  4. 4.
    WG Robertson, DS Scurr, A Smith, and RL Orwell, Clin. Chim. Acta 126: 91 (1982).PubMedCrossRefGoogle Scholar
  5. 5.
    GP Kasidas and GA Rose, Ann. Clin. Biochem. 22: 412 (1985).PubMedGoogle Scholar
  6. 6.
    GP Kasidas and GA Rose, Clin. Chim. Acta 154: 49 (1986).PubMedCrossRefGoogle Scholar
  7. 7.
    M Yanagawa, E Maeda, A Ichiyama, K Yamakawa, I Yamamoto, J Kawamura, and S Tada, in: this volume, p. 421.Google Scholar
  8. 8.
    A Halabe, NLM Wong, L Hagen, H Hughes, and RAL Sutton, in: this volume, p. 425.Google Scholar
  9. 9.
    M Menon, T Strzelecki, B McGraw, and C Scheid, in: this volume, p. 429.Google Scholar
  10. 10.
    T Sugimoto, H Osswald, K Yamamoto, T Kanazawa, T Kishimoto, M Senju, M Maekawa, and R Hautmann, in: this volume, p. 431.Google Scholar
  11. 11.
    J Lemann, Jr., JA Pleuss, and RW Gray, in: this volume, p. 435.Google Scholar
  12. 12.
    E Yendt and M Cohanim, in: this volume, p. 439.Google Scholar
  13. 13.
    S Cantaro, F Marchini, L Caló, G Gambaro, A Piccoli, HE Williams, B Baggio, and A Borsatti, in: this volume, p. 443.Google Scholar
  14. 14.
    K Yamakawa and J Kawamura, in: this volume, p. 447.Google Scholar
  15. 15.
    G Gambaro, F Marchini, M Bevilacqua, A Borsatti, and B Baggio, in: this volume, p. 451.0Google Scholar
  16. 16.
    DM Wilson, LH Smith, SB Erickson, VE Torres, and RR Liedtke, in: this volume, p. 453.Google Scholar
  17. 17.
    M Mancharan, PO Schwille, G Rümenapf, I Berger, R Meister, G Wolfel, and H Berens, in: this volume, p. 457.Google Scholar
  18. 18.
    PK Grover, RL Ryall, and VR Marshall, in: this volume, p. 461.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • L. H. Smith
    • 1
    • 2
  • B. Baggio
    • 1
    • 2
  1. 1.Division of NephrologyMayo ClinicRochesterUSA
  2. 2.Institute of Internal Medicine, Division of NephrologyUniversity of PadovaPadovaItaly

Personalised recommendations